Gregory Gregoriadis
President at The International Liposome Society
Gregory Gregoriadis active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The International Liposome Society | President | 01/01/2003 | - |
Career history of Gregory Gregoriadis
Former positions of Gregory Gregoriadis
| Companies | Position | Start | End |
|---|---|---|---|
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Director/Board Member | 13/10/2009 | 10/02/2014 |
| Chief Tech/Sci/R&D Officer | 01/01/1997 | 10/02/2014 | |
| Founder | 13/10/2009 | 10/02/2014 | |
| University of London | Corporate Officer/Principal | - | - |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | 17/11/2010 | - |
Training of Gregory Gregoriadis
| University of London | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Commercial Services | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| The International Liposome Society | Commercial Services |
- Stock Market
- Insiders
- Gregory Gregoriadis
- Experience
